Source comparison
MK-677 vs HGH Injections — Which Builds More Muscle?
Research from the University of Virginia School of Medicine found that MK-677 (ibutamoren) increased mean 24-hour growth hormone concentrations by 89% and IGF-1 levels by 79% after two weeks at 25mg daily. Without requiring injections, refrigeration, or prescr
This comparison does not assign a generated winner or score.
- Research from the University of Virginia School of Medicine found that MK-677 (ibutamoren) increased mean 24-hour growth hormone concentrations by 89% and IGF-1 levels by 79% after two weeks at 25mg daily. Without requiring injections, refrigeration, or prescription access. That raises an obvious question: if an oral compound can stimulate endogenous growth hormone secretion that effectively, why does anyone bother with recombinant HGH injections that cost 10–20× more and require strict cold chain storage?
- We've worked with research teams studying both compounds across multiple protocols. The gap between doing this comparison right and repeating surface-level marketing claims comes down to understanding three things most guides ignore: pulsatile versus continuous delivery kinetics, HPTA suppression risk, and the regulatory distinction between research compounds and FDA-approved biologics.
- What's the functional difference between MK-677 and recombinant HGH injections?
- MK-677 is an orally active ghrelin receptor agonist that stimulates the pituitary gland to release endogenous growth hormone in a pulsatile pattern matching natural secretion. Recombinant HGH (somatropin) is synthetic human growth hormone administered via subcutaneous injection, bypassing the pituitary entirely and delivering exogenous hormone directly into circulation. Both elevate serum IGF-1 levels. The primary mediator of growth hormone's anabolic effects. But MK-677 preserves natural feedback loops while exogenous HGH suppresses endogenous production through negative feedback at the hypothalamic-pituitary axis.
- Most comparisons frame this as 'natural versus synthetic,' which misses the mechanism. MK-677 doesn't contain growth hormone. It tells your body to make more of its own. Recombinant HGH is bioidentical to the hormone your pituitary produces, but administering it exogenously signals the hypothalamus to downregulate endogenous secretion within 48–72 hours of the first injection. This piece covers exactly how those mechanisms translate to practical outcomes, what the published literature shows about comparative efficacy, and which regulatory and safety distinctions matter if you're evaluating either compound for research applications.